MAXCYTE, INC. Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Maxcyte, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
  • Maxcyte, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 14.4 %, a 11.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 14.4 +1.48 +11.5% Jun 30, 2024
Q1 2024 14.1 +1.15 +8.9% Mar 31, 2024
Q4 2023 14 +1.72 +14% Dec 31, 2023
Q3 2023 13.3 +2.27 +20.5% Sep 30, 2023
Q2 2023 12.9 +3.71 +40.4% Jun 30, 2023
Q1 2023 12.9 +3.95 +44% Mar 31, 2023
Q4 2022 12.3 Dec 31, 2022
Q3 2022 11.1 Sep 30, 2022
Q2 2022 9.19 Jun 30, 2022
Q1 2022 8.97 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.